Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Drugs & Aging
|
October 19, 2015
Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management
Sonja Burgstaller, Petra Wiesinger, Reinhard Stauder
Current Hematologic Malignancy Reports
|
April 29, 2010
BCR-ABL-negative chronic myeloid leukemia
Sonja Burgstaller, Andreas Reiter, Nicholas C P Cross
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 2015
Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study
Beate Mayrbäurl, Johannes M Giesinger, Sonja Burgstaller, et al.
Clinical Kidney Journal
|
March 6, 2014
Three solid malignancies and a myelodysplastic syndrome with a protracted course after kidney transplantation
Friedrich C Prischl, Sonja Burgstaller, Manfred Wallner, et al.
European Journal of Gastroenterology & Hepatology
|
May 29, 2009
Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members
Beate Mayrbaeurl, Gisela Keller, Walter Schauer, et al.
Cancer Research
|
October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder
Francis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 1, 2015
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria
Gregor Aschauer, Richard Greil, Werner Linkesch, et al.
Molecular Cytogenetics
|
January 19, 2018
Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3)
Theodora Malli, Melanie Rammer, Sabrina Haslinger, et al.
Leukemia & Lymphoma
|
August 31, 2017
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
Sonja Burgstaller, Reinhard Stauder, Thomas Kuehr, et al.
Wiener Klinische Wochenschrift
|
March 29, 2013
Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis
Sonja Burgstaller, Michael Fridrik, Sabine Hojas, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Drugs & Aging
|
October 19, 2015
Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management
Sonja Burgstaller, Petra Wiesinger, Reinhard Stauder
Current Hematologic Malignancy Reports
|
April 29, 2010
BCR-ABL-negative chronic myeloid leukemia
Sonja Burgstaller, Andreas Reiter, Nicholas C P Cross
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 2015
Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study
Beate Mayrbäurl, Johannes M Giesinger, Sonja Burgstaller, et al.
Clinical Kidney Journal
|
March 6, 2014
Three solid malignancies and a myelodysplastic syndrome with a protracted course after kidney transplantation
Friedrich C Prischl, Sonja Burgstaller, Manfred Wallner, et al.
European Journal of Gastroenterology & Hepatology
|
May 29, 2009
Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members
Beate Mayrbaeurl, Gisela Keller, Walter Schauer, et al.
Cancer Research
|
October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder
Francis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 1, 2015
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria
Gregor Aschauer, Richard Greil, Werner Linkesch, et al.
Molecular Cytogenetics
|
January 19, 2018
Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3)
Theodora Malli, Melanie Rammer, Sabrina Haslinger, et al.
Leukemia & Lymphoma
|
August 31, 2017
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
Sonja Burgstaller, Reinhard Stauder, Thomas Kuehr, et al.
Wiener Klinische Wochenschrift
|
March 29, 2013
Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis
Sonja Burgstaller, Michael Fridrik, Sabine Hojas, et al.
Page
of 5